{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:45Z","timestamp":1740144225856,"version":"3.37.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81774302"],"award-info":[{"award-number":["No.81774302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Sichuan Province","award":["No. 2019YFS0022"],"award-info":[{"award-number":["No. 2019YFS0022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Diabetic macroangiopathy is a further complication of diabetes mellitus and is the leading cause of death for diabetic patients. Shenqi compound (SC) is a traditional Chinese medicine formula widely used in the treatment of diabetes and diabetic macroangiopathy. At present, there is only 1 systematic review on SC in the treatment of diabetes. However, no meta-analysis has evaluated the efficacy and safety of SC on diabetic macroangiopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>Three English database and four Chinese medical databases will be searched from its inception to February 2020. Then 2 methodological trained researchers will screen the qualified articles by reading the title, abstract, and full texts according to an established inclusion and exclusion criteria. The assessment of risk of bias will be conducted by using the Cochrane collaboration's tool. We will conduct meta-analyses for fasting blood glucose (FBG), postprandial blood glucose (PBG), glycated hemoglobin (HbA1c), and other outcomes. The heterogeneity of data will be evaluated by Cochrane <jats:italic toggle=\"yes\">\u03c7<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> and <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup> tests. We establish 3 hypotheses before the subgroup analysis actually starts: disease status at baseline, duration of intervention, type of concomitant medication. We will conduct sensitivity analysis to evaluate the stability of the results, funnel plot analysis, and Egger test to evaluate the publication bias, and assessment for the quality of evidence by the Grading of Recommendations Assessment, Development, and Evaluate system (GRADE).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results will be published at a peer-reviewed journal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In this study, we will systematically evaluate the evidence of SC in the treatment of diabetic macroangiopathy. Our research is supposed to provide evidence-based support for clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019682","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:26:52Z","timestamp":1586550412000},"page":"e19682","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of shenqi compound for the treatment of diabetic macroangiopathy"],"prefix":"10.1097","volume":"99","author":[{"given":"Zhipeng","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunguang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/CIRCRESAHA.115.306884","article-title":"Vascular complications of diabetes","volume":"118","author":"Beckman Joshua","year":"2016","journal-title":"Circ Res"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.1994.00420190068008","article-title":"Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy","volume":"154","author":"Klein","year":"1994","journal-title":"Arch Intern Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1001\/archinte.168.22.2440","article-title":"Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study","volume":"168","author":"Bash","year":"2008","journal-title":"Arch Intern Med"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.7326\/0003-4819-141-6-200409210-00006","article-title":"Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk","volume":"141","author":"Khaw","year":"2004","journal-title":"Ann Intern Med"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diab.43.8.960","article-title":"NIDDM and its metabolic control predict coronary heart disease in elderly subjects","volume":"43","author":"Kuusisto","year":"1994","journal-title":"Diabetes"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2337\/diacare.28.8.1965","article-title":"Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study","volume":"28","author":"Selvin","year":"2005","journal-title":"Diabetes Care"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9343(96)00383-X","article-title":"Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team","volume":"102","author":"Meigs","year":"1997","journal-title":"Am J Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3389\/fphys.2018.01857","article-title":"Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes","volume":"9","author":"Teodoro Jo\u00e3o","year":"2018","journal-title":"Front Physiol"},{"key":"R13-20230915","first-page":"CD008143","article-title":"T argeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus","author":"Hemmingsen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-151-6-200909150-00137","article-title":"Systematic review: glucose control and cardiovascular disease in type 2 diabetes","volume":"151","author":"Kelly","year":"2009","journal-title":"Ann Intern Med"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all-cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials","volume":"343","author":"Boussageon","year":"2011","journal-title":"BMJ"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"key":"R19-20230915","first-page":"2066","article-title":"Effects of Yangyin Yiqi Huoxue Method on oxidative stress and nitrification stress injury in diabetic GK rats","volume":"35","author":"Zhang","year":"2017","journal-title":"Chinese Journal of Traditional Chinese Medicine"},{"key":"R20-20230915","first-page":"249","article-title":"Effects of Shenqi compound on inflammatory markers in GK rats and its mechanisms","author":"Zhang","year":"2006","journal-title":"Traditional Chinese Medicine"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1871530319666190225113859","article-title":"Exploration of the effect and mechanism of ShenQi compound in a spontaneous diabetic rat model","volume":"19","author":"Liu","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"e0207683","DOI":"10.1371\/journal.pone.0207683","article-title":"Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules","volume":"13","author":"Gao","year":"2018","journal-title":"PLoS One"},{"key":"R23-20230915","first-page":"1297","article-title":"Clinical observation of 57 cases of type 2 diabetic macrovascular disease treated with Shenqi compound prescription","volume":"54","author":"Fu","year":"2013","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jdi.12352","article-title":"Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus","volume":"6","author":"Zhang","year":"2015","journal-title":"J Diabetes Investig"},{"key":"R25-20230915","first-page":"196","article-title":"Clinical observation on 100 cases of type 2 diabetic macrovascular disease treated by Shenqi compound prescription","volume":"17","author":"Han","year":"2017","journal-title":"Abstracts of the World's Latest Medical Information"},{"key":"R26-20230915","first-page":"2804","article-title":"Shenqi compound prescription combined with viglistine in the treatment of diabetic macrovascular disease","volume":"27","author":"Zhao","year":"2018","journal-title":"Journal of Modern Integrated Chinese and Western Medicine"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:28:50Z","timestamp":1694816930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019682"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":29,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019682","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}